Neuropathology of olfactory ensheathing cell transplantation into the brain of two amyotrophic lateral sclerosis (ALS) patients

Brain Pathology

Volumn 20, Issue 4, 2010, Pages 730-737

  Giordana, Maria Teresa ^a   Grifoni, Silvia ^a   Votta, Barbara ^a   Magistrello, Michela ^a   Vercellino, Marco ^a   Pellerino, Alessia ^a   Navone, Roberto ^a   Valentini, Consuelo ^b   Calvo, Andrea ^a   Chiò, Adriano ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b CTO HOSPITAL   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Neuropathology; Olfactory ensheathing cells; Transplantation

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN; CADAVER; CASE REPORT; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CHINA; CLINICAL ASSESSMENT; CONTROLLED STUDY; GLIA; HUMAN; IMPLANTATION; INFLAMMATION; ITALY; LONG TERM CARE; MALE; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE FIBER REGENERATION; NEUROPATHOLOGY; OLFACTORY ENSHEATHING CELL; OLFACTORY ENSHEATHING CELL TRANSPLANTATION; PATIENT SAFETY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; CYTOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY BULB; PATHOLOGY; PROCEDURES; TRANSPLANTATION;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; CELL TRANSPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROGLIA; OLFACTORY BULB; TREATMENT OUTCOME;

EID: 77953222299     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2009.00353.x     Document Type: Article

References (25)

1. Andrews MR, Stelzner DJ (2007) Evaluation of olfactory ensheathing and schwann cells after implantation into a dorsal injury of adult rat spinal cord. J Neurotrauma 24 : 1773 1792.
2. Boyd JG, Doucette R, Kawaja MD (2005) Defining the role of olfactory ensheathing cells in facilitating axon remyelination following damage to the spinal cord. FASEB J 19 : 694 703.
3. Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1 : 293 299.
4. Chen L, Huang H, Zhang J, Zhang F, Liu Y, Xi H et al (2007) Short-term outcome of olfactory ensheathing cell transplantation for treatment of amyotrophic lateral sclerosis. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 21 : 961 966.
5. Chew S, Khandji AG, Montes J, Mitsumoto H, Gordon PH (2007) Olfactory ensheathing glia injection in Beijing: misleading patients with ALS. Amyotroph Lateral Scler 8 : 314 316.
6. Christou YA, Moore HD, Shaw PJ, Monk PN (2007) Embryonic stem cells and prospects for their use in regenerative medicine approaches to motor neurone disease. Neuropathol Appl Neurobiol 33 : 485 498.
7. Conti L, Reitano E, Cattaneo E (2006) Neural stem cell systems: diversities and properties after transplantation in animal models of diseases. Brain Pathol 16 : 143 154.
8. Cyranoski D (2005) Fetal-cell therapy: paper chase. Nature 437 : 810 811.
9. Deshpande DM, Kim YS, Martinez T, Carmen J, Dike S, Shats I et al (2006) Recovery from paralysis in adult rats using embryonic stem cells. Ann Neurol 60 : 32 44.
10. Dewar D, Bentley D, Barnett SC (2007) Implantation of pure cultured olfactory ensheathing cells in an animal model of parkinsonism. Acta Neurochir (Wien) 149 : 407 414.
11. Dobkin BH, Curt A, Guest J (2006) Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repair 20 : 5 13.
12. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R et al (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344 : 710 719.
13. Gao J, Coggeshall RE, Tarasenko YI, Wu P (2005) Human neural stem cell-derived cholinergic neurons innervate muscle in motoneuron deficient adult rats. Neuroscience 131 : 257 262.
14. Giordana MT, Piccinini M, Grifoni S, De Marco G, Vercellino M, Magistrello M et al (2009) TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis. Brain Pathol E-pub ahead of print; DOI: 10.1111/j.1750-3639-2009.00284.x J, Herrera LP, Qian T (2006) Rapid recovery of segmental neurological function in a tetraplegic patient following transplantation of fetal olfactory bulb-derived cells. Spinal Cord 44 : 135 142.
15. Huang H, Chen L, Xi H, Wang H, Zhang J, Zhang F, Liu Y (2008) Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study. Clin Transplant 22 : 710 718.
16. Huang H, Chen L, Xi H, Wang Q, Zhang J, Liu Y, Zhang F (2009) Olfactory ensheathing cell transplantation for central nervous system diseases in 1255 patients. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 23 : 14 20.
17. Kato T, Honmou O, Uede T, Hashi K, Kocsis JD (2000) Transplantation of human olfactory ensheathing cells elicits remyelination of demyelinated rat spinal cord. Glia 30 : 209 218.
18. Lepore AC, Maragakis NJ (2007) Targeted stem cell transplantation strategies in ALS. Neurochem Int 50 : 966 975.
19. Lu P, Yang H, Culbertson M, Graham L, Roskams AJ, Tuszynski MH (2006) Olfactory ensheathing cells do not exhibit unique migratory or axonal growth-promoting properties after spinal cord injury. J Neurosci 26 : 11120 11130.
20. O'Toole DA, West AK, Chuah MI (2007) Effect of olfactory ensheathing cells on reactive astrocytes in vitro. Cell Mol Life Sci 64 : 1303 1309.
21. Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, Jenkins RB (1995) Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 55 : 5408 5414.
22. Smale KA, Doucette R, Kawaja MD (1996) Implantation of olfactory ensheathing cells in the adult rat brain following fimbria-fornix transection. Exp Neurol 137 : 225 233.
23. Suzuki M, Svendsen CN (2008) Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci 31 : 192 198.
24. World Medical Association (2008) Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects. Available at: http://www.wma.net/en/30publications/10policies/b3/index.html (accessed 2009).
25. Yamamoto M, Tanaka F, Tatsumi H, Sobue G (2008) A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies. Expert Opin Pharmacother 9 : 1845 1857.